171 related articles for article (PubMed ID: 32194687)
1. Identification of candidate RNA signatures in triple-negative breast cancer by the construction of a competing endogenous RNA network with integrative analyses of Gene Expression Omnibus and The Cancer Genome Atlas data.
Yan P; Tang L; Liu L; Tu G
Oncol Lett; 2020 Mar; 19(3):1915-1927. PubMed ID: 32194687
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer.
Yuan N; Zhang G; Bie F; Ma M; Ma Y; Jiang X; Wang Y; Hao X
Onco Targets Ther; 2017; 10():5883-5897. PubMed ID: 29276392
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
5. Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer.
Song X; Zhang C; Liu Z; Liu Q; He K; Yu Z
PeerJ; 2019; 7():e7522. PubMed ID: 31565554
[TBL] [Abstract][Full Text] [Related]
6. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
Tang Z; Wei G; Zhang L; Xu Z
Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
8. Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.
Li F; Li Q; Wu X
PLoS One; 2018; 13(2):e0192494. PubMed ID: 29420609
[TBL] [Abstract][Full Text] [Related]
9. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
[TBL] [Abstract][Full Text] [Related]
11. Construction and Investigation of a lncRNA-Associated ceRNA Regulatory Network in Cholangiocarcinoma.
Long J; Xiong J; Bai Y; Mao J; Lin J; Xu W; Zhang H; Chen S; Zhao H
Front Oncol; 2019; 9():649. PubMed ID: 31448221
[No Abstract] [Full Text] [Related]
12. Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma.
Liang YC; Wu YP; Chen DN; Chen SH; Li XD; Sun XL; Wei Y; Ning X; Xue XY
Cell Physiol Biochem; 2018; 51(6):2916-2924. PubMed ID: 30562748
[TBL] [Abstract][Full Text] [Related]
13. lncRNA OSTN-AS1 May Represent a Novel Immune-Related Prognostic Marker for Triple-Negative Breast Cancer Based on Integrated Analysis of a ceRNA Network.
Liu Z; Mi M; Li X; Zheng X; Wu G; Zhang L
Front Genet; 2019; 10():850. PubMed ID: 31572452
[TBL] [Abstract][Full Text] [Related]
14. Integrative Analysis of Long Noncoding RNA (lncRNA), microRNA (miRNA) and mRNA Expression and Construction of a Competing Endogenous RNA (ceRNA) Network in Metastatic Melanoma.
Wang LX; Wan C; Dong ZB; Wang BH; Liu HY; Li Y
Med Sci Monit; 2019 Apr; 25():2896-2907. PubMed ID: 31004080
[TBL] [Abstract][Full Text] [Related]
15. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
17. RNA atlas and competing endogenous RNA regulation in tissue-derived exosomes from luminal B and triple-negative breast cancer patients.
Wang J; Zhang X; You Z; Meng Y; Fan X; Qiao G; Pang D
Front Oncol; 2023; 13():1113115. PubMed ID: 37483500
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
Luo Q; Cui M; Deng Q; Liu J
Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
[TBL] [Abstract][Full Text] [Related]
19. Construction and Analysis of the Tumor-Specific mRNA-miRNA-lncRNA Network in Gastric Cancer.
Zheng X; Wang X; Zheng L; Zhao H; Li W; Wang B; Xue L; Tian Y; Xie Y
Front Pharmacol; 2020; 11():1112. PubMed ID: 32848739
[TBL] [Abstract][Full Text] [Related]
20. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
